News

Santhera receives FDA Fast Track Designation for Omigapil for the Treatment of Congenital Muscular Dystrophies

Press release 20 May 2016

20 maggio 2016

Non-invasive Imaging and Tracking of Engineered Human Muscle Precursor Cells for Skeletal Muscle Tissue Engineering Using Positron Emission Tomography.

Haralampieva D, Betzel T, Dinulovic I, Salemi S, Stoelting M, Krämer S, Schibli R, Sulser T, Handschin C, Eberli D, Ametamey SM. J Nucl Med. 2016 May 19

19 maggio 2016

Functional characterization of orbicularis oculi and extraocular muscles.

Sekulic-Jablanovic M, Ullrich ND, Goldblum D, Palmowski-Wolfe A, Zorzato F, Treves S. J Gen Physiol. 2016 May;147(5):395-406.

13 maggio 2016

Alterations to mTORC1 signaling in the skeletal muscle differentially affect whole-body metabolism.

Guridi M, Kupr B, Romanino K, Lin S, Falcetta D, Tintignac L, Rüegg MA. Skelet Muscle. 2016 Mar 21;6:13.

04 aprile 2016

In vivo assessment of muscle membrane properties in myotonic dystrophy.

Tan SV, Z'Graggen WJ, Boërio D, Turner C, Hanna MG, Bostock H. Muscle Nerve. 2016 Jan 20

04 marzo 2016

Improved Muscle Function in Duchenne Muscular Dystrophy through L-Arginine and Metformin: An Investigator-Initiated, Open-Label, Single-Center, Proof-Of-Concept-Study.

Hafner P, Bonati U, Erne B, Schmid M, Rubino D, Pohlman U, Peters T, Rutz E, Frank S, Neuhaus C, Deuster S, Gloor M, Bieri O, Fischmann A, Sinnreich M, Gueven N, Fischer...

24 febbraio 2016

<< Prima < Precedente 231-240 241-250 251-260261-270271-280 281-290 291-300 Prossima >Ultima >>

News

Santhera receives FDA Fast Track Designation for Omigapil for the Treatment of Congenital Muscular Dystrophies

Non-invasive Imaging and Tracking of Engineered Human Muscle Precursor Cells for Skeletal Muscle Tissue Engineering Using Positron Emission Tomography.

Functional characterization of orbicularis oculi and extraocular muscles.

Alterations to mTORC1 signaling in the skeletal muscle differentially affect whole-body metabolism.

In vivo assessment of muscle membrane properties in myotonic dystrophy.

Improved Muscle Function in Duchenne Muscular Dystrophy through L-Arginine and Metformin: An Investigator-Initiated, Open-Label, Single-Center, Proof-Of-Concept-Study.

Cardiac mTOR complex 2 preserves ventricular function in pressure-overload hypertrophy.

Central and peripheral defects in motor units of the diaphragm of spinal muscular atrophy mice.

Skeletal muscle as an endocrine organ: PGC-1alfa, myokines and exercise.

Activation of mTORC1 in skeletal muscle regulates whole-body metabolism through FGF21.

La Fondazione

FSRMM